Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: The Cardio133 trial

European Heart Journal

Volumn 35, Issue 19, 2014, Pages 1263-1274

  Nasseri, Boris A ^a   Ebell, Wolfram ^b   Dandel, Michael ^a   Kukucka, Marian ^a   Gebker, Rolf ^a   Doltra, Adelina ^a   Knosalla, Christoph ^a   Choi, Yeong Hoon ^c   Hetzer, Roland ^a   Stamm, Christof ^a,c  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Berlin Brandenburg Center for Regenerative Therapies   (Germany)

Author keywords

Bypass; Cells; Impaired LV function; Infarction; Ischaemic heart disease

Indexed keywords

CD133 ANTIGEN; GADOLINIUM; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE;

ADULT; ANEMIA; ARTICLE; ATRIOVENTRICULAR BLOCK; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW BIOPSY; BRONCHUS TUMOR; CANDIDEMIA; CARDIOVASCULAR MAGNETIC RESONANCE; CELL SELECTION; CHOLECYSTITIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; ECHOCARDIOGRAPHY; EXERCISE; EXERCISE TEST; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART MUSCLE REGENERATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE FLUTTER; HEART VENTRICLE TACHYCARDIA; HEMATOMA; HUMAN; HUMAN TISSUE; HYPOTENSION; INCIDENCE; ISCHEMIA; ISCHEMIC HEART DISEASE; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MEDIASTINITIS; NEW YORK HEART ASSOCIATION CLASS; OPERATIVE BLOOD LOSS; PACEMAKER FAILURE; PARALYTIC ILEUS; PERICARDIAL EFFUSION; PLEURA EFFUSION; PNEUMOTHORAX; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATE CARCINOMA; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FAILURE; SEPSIS; SINUS BRADYCARDIA; SUDDEN CARDIAC DEATH; THROMBOCYTOSIS; TREATMENT OUTCOME; TWO DIMENSIONAL ECHOCARDIOGRAPHY; WALKING; WOUND FLUID; WOUND HEALING IMPAIRMENT; AUTOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; HEART; INTRALESIONAL DRUG ADMINISTRATION; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; MYOCARDIAL ISCHEMIA; PHYSIOLOGY; PROCEDURES; REGENERATION; STEM CELL TRANSPLANTATION; THERAPY;

ANTIGENS, CD; BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; CORONARY ARTERY BYPASS; FEMALE; GLYCOPROTEINS; HEART; HUMANS; INJECTIONS, INTRALESIONAL; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PEPTIDES; REGENERATION; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84897952440     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu007     Document Type: Article

References (34)

1. Marelli D, Desrosiers C, el-Alfy M, Kao RL, Chiu RC. Cell transplantation for myocardial repair: an experimental approach. Cell Transplant 1992;1:383-390.
2. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D,Wang J, Homma S, Edwards NM, Itescu S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001;7:430-436.
3. Ma N, Ladilov Y, Moebius JM, Ong L, Piechaczek C, David A, Kaminski A, Choi YH, LiW, Egger D, Stamm C, Steinhoff G. Intramyocardial delivery of human CD133+ cells in a SCID mouse cryoinjury model: Bone marrow vs. cord blood-derived cells. Cardiovasc Res 2006;71:158-169.
4. StammC, Nasseri B, Choi YH, Hetzer R. Cell therapy for heart disease: great expectations, as yet unmet. Heart Lung Circ 2009;18:245-256.
5. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, Grunwald F, Aicher A, Urbich C, Martin H, Hoelzer D, Dimmeler S, Zeiher AM. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002;106:3009-3017.
6. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H. Intracoronary autologous bone-marrowcell transfer after myocardial infarction: theBOOSTrandomised controlled clinical trial. Lancet 2004;364:141-148.
7. Jeevanantham V, Butler M, Saad A, Abdel-Latif A, Zuba-Surma EK, Dawn B. Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation 2012;126: 551-568.
8. Perin EC, Willerson JT, Pepine CJ, Henry TD, Ellis SG, Zhao DX, Silva GV, Lai D, Thomas JD, Kronenberg MW, Martin AD, Anderson RD, Traverse JH, Penn MS, Anwaruddin S, Hatzopoulos AK, Gee AP, Taylor DA, Cogle CR, Smith D, Westbrook L, Chen J, Handberg E, Olson RE, Geither C, Bowman S, Francescon J, Baraniuk S, Piller LB, Simpson LM, Loghin C, Aguilar D, Richman S, Zierold C, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Moye LA, Simari RD. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. JAMA 2012;307: 1717-1726.
9. Perin EC, Silva GV, Zheng Y, Gahremanpour A, Canales J, Patel D, Fernandes MR, Keller LH, Quan X, Coulter SA, Moore WH, Herlihy JP, Willerson JT. Randomized, double-blind pilot study of transendocardial injection of autologous aldehyde dehydrogenase-bright stem cells in patients with ischemic heart failure. Am Heart J 2012;163:415-421.
10. Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Mesquita CT, Rossi MI, Carvalho AC, Dutra HS, Dohmann HJ, Silva GV, Belem L, Vivacqua R, Rangel FO, Esporcatte R, Geng YJ, Vaughn WK, Assad JA, Mesquita ET, Willerson JT. Transendocardial, autologous bone marrowcell transplantation for severe, chronic ischemic heart failure. Circulation 2003;107:2294-2302.
11. Assmus B, Fischer-Rasokat U, Honold J, Seeger FH, Fichtlscherer S, Tonn T, Seifried E, Schachinger V, Dimmeler S, Zeiher AM. Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of theTOPCARE-CHDRegistry. Circ Res 2007;100:1234-1241.
12. Strauer BE, Brehm M, Zeus T, Bartsch T, Schannwell C, Antke C, Sorg RV, Kogler G, Wernet P, MullerHW, Kostering M. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study. J Am Coll Cardiol 2005;46:1651-1658.
13. Nasseri BA, Kukucka M, Dandel M, Knosalla C, Choi YH, Ebell W, Hetzer R, Stamm C. Two-dimensional speckle tracking strain analysis for efficacy assessment of myocardial cell therapy. Cell Transplant 2009;18:361-370.
14. Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C, Klinge H, Schumichen C, Nienaber CA, Freund M, Steinhoff G. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003;361:45-46.
15. Patel AN, Geffner L, Vina RF, Saslavsky J, UrschelHCJr, Kormos R, Benetti F. Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study. J Thorac Cardiovasc Surg 2005;130: 1631-1638.
16. Stamm C, Kleine HD, Choi YH, Dunkelmann S, Lauffs JA, Lorenzen B, David A, Liebold A, Nienaber C, Zurakowski D, Freund M, Steinhoff G. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J Thorac Cardiovasc Surg 2007;133: 717-725.
17. Yerebakan C, Kaminski A,Westphal B, Donndorf P, Glass A, Liebold A, Stamm C, Steinhoff G. Impact of preoperative left ventricular function and time from infarction on the long-term benefits after intramyocardial CD133(+) bone marrow stem cell transplant. J Thorac Cardiovasc Surg 2011;142:1530-1539.
18. Gaipa G, Tilenni M, Straino S, Burba I, Zaccagnini G, Belotti D, Biagi E, Valentini M, Perseghin P, Parma M, Campli CD, Biondi A, Capogrossi MC, Pompilio G, Pesce M. GMP-based CD133(+) cells isolation maintains progenitor angiogenic properties and enhances standardization in cardiovascular cell therapy. J Cell Mol Med 2010;14:1619-1634.
19. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-1453.
20. Guyatt GH. Measurement of health-related quality of life in heart failure. J Am Coll Cardiol 1993;22(4 Suppl A):185A-191A.
21. Machin D, Campbell MJ, Fayers P, Pinol A. Sample Size Tables for Clinical Studies. 2nd ed. Oxford: Blackwell Science; 1997.
22. Conover WJ. Practical Nonparametric Statistics. 3rd ed. New York: Wiley; 1999.
23. Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F, Daly C, De Backer G, Hjemdahl P, Lopez-Sendon J, Marco J, Morais J, Pepper J, Sechtem U, Simoons M, Thygesen K, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL. Guidelines on the management of stable angina pectoris: executive summary: the task force on the management of stable angina pectoris of the European Society of Cardiology. Eur Heart J 2006;27:1341-1381.
24. WojakowskiW,Tendera M, Kucia M, Zuba-Surma E, Milewski K,Wallace-Bradley D, Kazmierski M, Buszman P, Hrycek E, CybulskiW, Kaluza G, Wieczorek P, Ratajczak J, Ratajczak MZ. Cardiomyocyte differentiation of bone marrow-derived Oct-4+-CXCR4+SSEA-1+ very small embryonic-like stem cells. Int J Oncol 2010;37: 237-247.
25. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, Olweus J, Kearney J, Buck DW. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997;90:5002-5012.
26. Uchida N, BuckDW,He D, Reitsma MJ, Masek M, PhanTV, Tsukamoto AS, Gage FH, Weissman IL. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA 2000;97:14720-14725.
27. Grosse-Gehling P, Fargeas CA, Dittfeld C, Garbe Y, Alison MR, Corbeil D, Kunz-Schughart LA. CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges. J Pathol 2013;229:355-378.
28. Pompilio G, Cannata A, Peccatori F, Bertolini F, Nascimbene A, Capogrossi MC, Biglioli P. Autologous peripheral blood stem cell transplantation for myocardial regeneration: a novel strategy for cell collection and surgical injection. Ann Thorac Surg 2004;78:1808-1812.
29. Babin-Ebell J, Sievers HH, Charitos EI, Klein HM, Jung F, Hellberg AK, Depping R, Sier HA, Marxsen J, Stoelting S, Kraatz EG,Wagner KF. Transmyocardial laser revascularization combined with intramyocardial endothelial progenitor cell transplantation in patients with intractable ischemic heart disease ineligible for conventional revascularization: preliminary results in a highly selected small patient cohort. Thorac Cardiovasc Surg 2010;58:11-16.
30. Reyes G, Allen KB, Alvarez P, Alegre A, Aguado B, Olivera M, Caballero P, Rodriguez J, Duarte J. Mid term results after bone marrow laser revascularization for treating refractory angina. BMC Cardiovasc Disord 2010;10:42.
31. Stamm C, Nasseri B, Drews T, Hetzer R. Cardiac cell therapy: a realistic concept for elderly patients? Exp Gerontol 2008;43:679-690.
32. Assmus B,Walter DH, Seeger FH, LeistnerDM,Steiner J, Ziegler I, Lutz A, KhaledW, Klotsche J, TonnT,Dimmeler S, Zeiher AM. Effect of shockwave- facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial. JAMA 2010;309:1622-1631.
33. Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LE, Berman D, Czer LS, Marban L, Mendizabal A, Johnston PV, Russell SD, Schuleri KH, Lardo AC, Gerstenblith G, Marban E. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 2012;379:895-904.
34. Bolli R, Chugh AR, D'Amario D, Loughran JH, Stoddard MF, Ikram S, Beache GM, Wagner SG, Leri A, Hosoda T, Sanada F, Elmore JB, Goichberg P, Cappetta D, Solankhi NK, Fahsah I, Rokosh DG, Slaughter MS, Kajstura J, Anversa P. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 2011;378:1847-1857.